Processing your payment...
Please do not close your browser.

Aprotinin Market Global Growth, Trends and Forecast (2022-2029) By Indication (Heart Surgery (bypass surgery), Liver Surgery, Grafting, Pancreatitis) By Form (Aprotinin from Bovine Lung, Recombinant Aprotinin) and By Regions

05 Jul, 2022 | 158 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the forecast period, the Aprotinin Market will register a CAGR of 4.45 % in revenue, and the global market size will reach USD 221 Billion by 2029.

Aprotinin Market Overview

The worldwide market for aprotinin may be divided into sections based on indication, form, end-user, and geography. The worldwide market may be divided into heart surgery (bypass surgery), liver surgery, graft surgery, pancreatitis, and other categories based on the indication. The pharmaceutical industry, diagnostic labs, academic institutions, contract research organizations, hospitals, ambulatory surgery centers, clinics, and pharmacies may all be classified as end-users in the worldwide aprotinin market. The Aprotinin market may be segmented into recombinant Aprotinin and Aprotinin from bovine lungs based on form.

Aprotinin, also known as BPTI (bovine pancreatic trypsin inhibitor), is a medication made of proteins. Aprotinin has been used to reduce bleeding during difficult surgical operations, such as heart and liver surgeries since it can decrease fibrinolysis. Aprotinin is often given via injection. It is given to unconscious individuals since it is mostly used during surgery.

Aprotinin is also used to lessen the need for blood transfusions during surgery and to lessen end-organ damage that arises from hypotension brought on by blood loss during surgery. Aprotinin is recommended for use as a preventative measure in patients having cardiopulmonary bypass during coronary artery bypass graft surgery who are more likely to experience blood loss and blood transfusion needs.

What is our Aprotinin Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029

 

CAGR of 4.45 % during the review period (2022 to 2029).

 

By Indication

  • Heart Surgery (bypass surgery)
  • Liver Surgery
  • Grafting
  • Pancreatitis
  • Others

 

By Form

 

 

 

 

  • Aprotinin from Bovine Lung
  • Recombinant Aprotinin

By End-User

  • Pharmaceutical Companies
  • Diagnostic Laboratories
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Pharmacies

 

 

 

By Companies

  • Sigma-Aldrich
  • Beijing Geyuantianrun Bio-tech
  • Cayman Chemical
  • Taj Pharmaceuticals Limited
  • Guangdong Techpool Bio-pharma
  • A.S. Joshi & Company
  • Enzymeking Biotechnology
  • AdooQ BioScience
  • ProSpec
  • Yaxin Biotechnology
  • AMRESCO
  • PanReac AppliChem
  • Runhao

 

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

Base Year

2022

 

Historical Year

 

 

2017 to 2021

Forecast Year

 

2022 to 2029

Number of Pages

158

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Frequently Asked Questions

What are the current market size and compound annual growth rate (CAGR) of the Aprotinin market during the forecast period (2022-2029)?

The Aprotinin Market is growing at a CAGR of 4.45 % over the next 7 years.

Who are the key players in Aprotinin Market?

Sigma-Aldrich, Beijing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited, Guangdong Techpool Bio-pharma, A.S. Joshi & Company, Enzymeking Biotechnology, AdooQ BioScience, ProSpec, Yaxin Biotechnology, AMRESCO, PanReac AppliChem, Runhao, Others.

What region does this Aprotinin Market report cover?

North America (the United States, Canada, and Mexico), Europe (Germany, France, UK, Russia, and Italy), Asia-Pacific (China, Japan, Korea, India, and Southeast Asia), South America (Brazil, Argentina, Colombia, etc.), The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What is the significant Indication of the Aprotinin Market?

Heart Surgery (bypass surgery), Liver Surgery, Grafting, Pancreatitis, and Others.

What is the significant Form of the Aprotinin Market?

Aprotinin from Bovine Lung, Recombinant Aprotinin

Who are the Major Players in Aprotinin Market?

Market Growth Reports lists out all the Aprotinin Market companies that are presently striving to reduce the impact of the Covid-19 pandemic on the Market- Sigma-Aldrich, Beijing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited, Guangdong Techpool Bio-pharma, A.S. Joshi & Company, Enzymeking Biotechnology, AdooQ BioScience, ProSpec, Yaxin Biotechnology, AMRESCO, PanReac AppliChem, Runhao, Others

Industry News:

By inhibiting SARS-CoV-2 from entering host cells, aprotinin may decrease viral replication.

Researchers from Goethe University Frankfurt and the University of Kent demonstrated in laboratory tests that the protease inhibitor aprotinin stopped cells from becoming infected by SARS-CoV2 in a recent clinical investigation from Spain. According to the authors of the clinical trial, patients who get an aprotinin aerosol may leave the hospital much sooner.

What are the major Indication, Forms, and End Users for Aprotinin Market?

By Indication, it is segmented into

  • Heart Surgery (bypass surgery)
  • Liver Surgery
  • Grafting
  • Pancreatitis
  • Others

By Form, it is segmented into

  • Aprotinin from Bovine Lung
  • Recombinant Aprotinin

By End User, it is segmented into

  • Pharmaceutical Companies
  • Diagnostic Laboratories
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Pharmacies

Aprotinin Market Regional Analysis

The market for aprotinin is anticipated to be dominated by North America. The region's Aprotinin market is driven by an increase in bypass operations and a rise in the number of patients with chronic illnesses. The Aprotinin market in North America is augmented by the presence of significant companies like Sigma-Aldrich and AMRESCO. The business in the area is further boosted by advantageous reimbursement policies and technical improvements. Additionally, the market in North America is driven by growth in accident and injury cases.

Due to factors such as rising healthcare costs, an aging population, a rise in disposable income, a higher prevalence of chronic diseases, accelerating research and development activities, and significant investment in R&D, the market in the Asia Pacific is predicted to grow significantly during the forecast period. Additionally, the market in the area is being driven by an increase in knowledge regarding the use of aprotinin in major operations, particularly grafting. Product approvals and more product launches are further fueling the Asia Pacific market.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America
  1. INTRODUCTION
    1. MARKET DEFINITION
    2. MARKET DYNAMICS
    3. MARKET SEGMENTATION
    4. REPORT TIMELINES
    5. KEY STAKEHOLDERS
  2. RESEARCH METHODOLOGY
    1. DATA MINING
      1. SECONDARY RESEARCH
      2. PRIMARY RESEARCH
      3. SUBJECT MATTER EXPERT ADVICE
    2. QUALITY CHECK
    3. FINAL REVIEW
      1. DATA TRIANGULATION
      2. BOTTOM-UP APPROACH
      3. TOP-DOWN APPROACH
      4. RESEARCH FLOW
  3. EXECUTIVE SUMMARY
    1. INTRODUCTION
    2. GLOBAL APROTININ MARKET BY INDICATION
    3. GLOBAL APROTININ MARKET BY FORM
    4. GLOBAL APROTININ MARKET, BY END USER
  4. MARKET DYNAMICS
    1. DRIVERS
      1. INCREASING DEMAND FOR MSM SUPPLEMENT
    2. RESTRAINTS
      1. STRINGENT ENVIRONMENTAL REGULATIONS
      2. HIGH COST ON MATERIALS
    3. OPPORTUNITIES
      1. APROTININ MARKET GROWTH
    4. APPLICATION OF APROTININ MARKET IMPACT OF COVID 19
  5. GLOBAL APROTININ MARKET, BY INDICATION
    1. INTRODUCTION
    2. HEART SURGERY (BYPASS SURGERY)
    3. LIVER SURGERY
    4. GRAFTING
    5. PANCREATITIS
    6. OTHERS
  6. GLOBAL APROTININ MARKET, BY FORM
    1. INTRODUCTION
    2. APROTININ FROM BOVINE LUNG
    3. RECOMBINANT APROTININ
  7. GLOBAL APROTININ MARKET, BY END USER
    1. INTRODUCTION
    2. PHARMACEUTICAL COMPANIES
    3. DIAGNOSTIC LABORATORIES
    4. HOSPITALS
    5. AMBULATORY SURGICAL CENTERS
    6. CLINICS
    7. PHARMACIES
  8. GLOBAL APROTININ MARKET, BY REGION
    1. NORTH AMERICA
      1. US
      2. CANADA
      3. MEXICO
    2. EUROPE
      1. GERMANY
      2. FRANCE
      3. UK
      4. ITALY
      5. RUSSIA
      6. REST OF EUROPE
    3. APAC
      1. CHINA
      2. SOUTH KOREA
      3. JAPAN
      4. INDIA
      5. AUSTRALIA
      6. ASEAN
      7. REST OF APAC
    4. MIDDLE EAST AND AFRICA
      1. SAUDI ARABIA
      2. UAE
      3. SOUTH AFRICA
      4. TURKEY
      5. REST OF MEA
    5. SOUTH AMERICA
      1. BRAZIL
      2. REST OF MEA
      3. ARGENTINA
      4. REST OF SOUTH AMERICA
  9. COMPETITIVE LANDSCAPE
    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
    2. AND AGREEMENTS
      1. KEY DEVELOPMENT
    3. MARKET SHARE PERCENT/RANKING ANALYSIS
    4. STRATEGIES ADOPTED BY LEADING PLAYERS
  10. COMPANY PROFILES
    1. BUSINESS OVERVIEW
    2. COMPANY SNAPSHOT
    3. PRODUCT BENCHMARKING
    4. STRATEGIC INITIATIVES
      1. SIGMA-ALDRICH
      2. BEIJING GEYUANTIANRUN BIO-TECH
      3. CAYMAN CHEMICAL
      4. TAJ PHARMACEUTICALS LIMITED
      5. GUANGDONG TECHPOOL BIO-PHARMA
      6. A.S. JOSHI & COMPANY
      7. ENZYMEKING BIOTECHNOLOGY
      8. ADOOQ BIOSCIENCE
      9. PROSPEC
      10. YAXIN BIOTECHNOLOGY
      11. AMRESCO
      12. PANREAC APPLICHEM
      13. RUNHAO

 

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla